PT  - JOURNAL ARTICLE
AU  - Yek, Christina
AU  - Li, Yimei
AU  - Pacheco, Andrea R.
AU  - Lon, Chanthap
AU  - Duong, Veasna
AU  - Dussart, Philippe
AU  - Chea, Sophana
AU  - Lay, Sreyngim
AU  - Man, Somnang
AU  - Kimsan, Souv
AU  - Huch, Chea
AU  - Leang, Rithea
AU  - Huy, Rekol
AU  - Brook, Cara E.
AU  - Manning, Jessica E.
TI  - Dengue in Cambodia 2002-2020: Cases, Characteristics and Capture by National Surveillance
AID  - 10.1101/2023.04.27.23289207
DP  - 2023 Jan 01
TA  - medRxiv
PG  - 2023.04.27.23289207
4099  - http://medrxiv.org/content/early/2023/04/28/2023.04.27.23289207.short
4100  - http://medrxiv.org/content/early/2023/04/28/2023.04.27.23289207.full
AB  - Objective Data from 19 years of national dengue surveillance in Cambodia (2002-2020) were analyzed to describe trends in dengue case characteristics and incidence.Methods Generalized additive models were fitted to dengue case incidence and characteristics (mean age, case phenotype, fatality) over time. Dengue incidence in a pediatric cohort study (2018-2020) was compared to national data during the same period to evaluate disease under-estimation by national surveillance.Findings During 2002-2020, there were 353,270 cases of dengue (average age-adjusted incidence 1.75 cases/ 1,000 persons/ year) recorded in Cambodia, with an estimated 2.1-fold increase in case incidence between 2002 and 2020 (slope = 0.0058, SE = 0.0021, p = 0.006). Mean age of infected individuals increased from 5.8 years in 2002 to 9.1 years in 2020 (slope = 0.18, SE = 0.088, p <0.001); case fatality rates decreased from 1.77% in 2002 to 0.10% in 2020 (slope = - 0.16, SE = 0.0050, p <0.001). When compared to cohort data, national data under-estimated clinically apparent dengue case incidence by 5.0-fold (95% CI 0.2 – 26.5), and overall dengue case incidence (both apparent and inapparent cases) by 33.6-fold (range: 18.7-53.6).Conclusion Dengue incidence in Cambodia is increasing and disease is shifting to older pediatric populations. National surveillance continues to under-estimate case numbers. Future interventions should account for disease under-estimation and shifting demographics for scaling and to target appropriate age groups.Competing Interest StatementThe authors have declared no competing interest.Clinical Protocols https://clinicaltrials.gov/ct2/show/NCT03534245 Funding StatementThis study was funded in part by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health (U.S.A.), and by the Merck Investigator Studies Program (Award #60826).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:National dengue surveillance data used in this study were de-identified and are publicly available by request from the Cambodian Ministry of Health. Monthly dengue incidence is also accessible via WHO weekly reports.19 The U.S. National Institutes of Health and the National Ethics Committee on Human Research in Cambodia gave ethical approval for this work (pediatric protocol NCT03534245).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors.